Cargando…

A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel

Mortality in colorectal cancer (CRC) remains high, resulting in 860,000 deaths annually. Carcinoembryonic antigen is widely used in clinics for CRC patient follow-up, despite carrying a limited prognostic value. Thus, an obvious need exists for multivariate prognostic models. We analyzed 48 biomarke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Björkman, Kajsa, Jalkanen, Sirpa, Salmi, Marko, Mustonen, Harri, Kaprio, Tuomas, Kekki, Henna, Pettersson, Kim, Böckelman, Camilla, Haglund, Caj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900104/ https://www.ncbi.nlm.nih.gov/pubmed/33619304 http://dx.doi.org/10.1038/s41598-020-80785-1

Ejemplares similares

Prognostic Values of Tissue and Serum Angiogenic Growth Factors Depend on the Phenotypic Subtypes of Colorectal Cancer
por: Kasurinen, Jussi Herman, et al.
Publicado: (2023)

A comparative study of two PODXL antibodies in 840 colorectal cancer patients
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Pancreatic cancer survival prediction via inflammatory serum markers
por: Lanki, Mira, et al.
Publicado: (2022)

Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer
por: Böckelman, Camilla, et al.
Publicado: (2018)

Association between local immune cell infiltration, mismatch repair status and systemic inflammatory response in colorectal cancer
por: Gunnarsson, Ulf, et al.
Publicado: (2020)

The Prognostic Importance of CD20(+) B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets
por: Edin, Sofia, et al.
Publicado: (2019)

Stage I–IV Colorectal Cancer Prognosis Can Be Predicted by Type and Number of Intratumoral Macrophages and CLEVER-1(+) Vessel Density
por: Ålgars, Annika, et al.
Publicado: (2021)

REG4 Independently Predicts Better Prognosis in Non-Mucinous Colorectal Cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients
por: Beilmann-Lehtonen, Ines, et al.
Publicado: (2023)

The prognostic role of tissue TLR2 and TLR4 in colorectal cancer
por: Beilmann-Lehtonen, Ines, et al.
Publicado: (2020)

Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2019)

The possible dual role of Ang-2 in the prognosis of pancreatic cancer
por: Roos-Mattila, Matilda, et al.
Publicado: (2023)

N-glycomic profiling of colorectal cancer according to tumor stage and location
por: Holm, Matilda, et al.
Publicado: (2020)

Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis
por: Arpalahti, Leena, et al.
Publicado: (2018)

Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma
por: Mattila, Nora, et al.
Publicado: (2018)

Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer
por: Kaprio, Tuomas, et al.
Publicado: (2021)

N-glycomic Profiling as a Tool to Separate Rectal Adenomas from Carcinomas
por: Kaprio, Tuomas, et al.
Publicado: (2015)

N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm
por: Nieminen, Heini, et al.
Publicado: (2023)

Host CD73 impairs anti-tumor immunity
por: Salmi, Marko, et al.
Publicado: (2012)

Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation
por: Salmi, Marko, et al.
Publicado: (2019)

Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer
por: Lehtomäki, Kaisa, et al.
Publicado: (2023)

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer
por: Lehtomäki, Kaisa, et al.
Publicado: (2021)

Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer
por: Lanki, Mira, et al.
Publicado: (2019)

The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy
por: Nurmi, Anna Maria, et al.
Publicado: (2022)

Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis
por: Saraswat, Mayank, et al.
Publicado: (2017)

Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer
por: Eurola, Annika, et al.
Publicado: (2022)

Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome
por: Kasurinen, Aaro, et al.
Publicado: (2019)

High PROX1 expression in gastric cancer predicts better survival
por: Laitinen, Alli, et al.
Publicado: (2017)

High TKTL1 expression as a sign of poor prognosis in colorectal cancer with synchronous rather than metachronous liver metastases
por: Peltonen, Reetta, et al.
Publicado: (2020)

MRI follow-up for pancreatic intraductal papillary mucinous neoplasm: an ultrashort versus long protocol
por: Johansson, Katarina, et al.
Publicado: (2021)

Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors
por: Puputti, Marjut, et al.
Publicado: (2009)

Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma
por: Kaasinen, Mirjami, et al.
Publicado: (2022)

Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy
por: Vehviläinen, Sini, et al.
Publicado: (2021)

CD73 Activity is Dispensable for the Polarization of M2 Macrophages
por: Eichin, Dominik, et al.
Publicado: (2015)

Podocalyxin as a Prognostic Marker in Gastric Cancer
por: Laitinen, Alli, et al.
Publicado: (2015)

Endoscopic sphincterotomy and risk of cholangiocarcinoma: a population-based cohort study in Finland and Sweden
por: Strömberg, Cecilia, et al.
Publicado: (2016)

High serum MMP-14 predicts worse survival in gastric cancer
por: Kasurinen, Aaro, et al.
Publicado: (2018)

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Salmiheimo, Aino, et al.
Publicado: (2016)

Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer
por: Eurola, Annika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nnjk6qbd4krej3p306tnnm7ik7